Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

RIPK1 inhibitors might help prevent alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Phospholipids help plant proteins move by regulating receptor interactions.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Radioiodine-131 significantly accumulates in skin and hair.

OXI1 kinase is essential for plant defense and root hair growth in Arabidopsis.

Pre-natal, internal, and external factors may contribute to the development of Autism Spectrum Disorder (ASD).

Mutations in certain receptors can cause diseases and offer new treatment options.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Illegal wildlife captivity poses health risks and highlights the need for conservation and public health awareness.

Raltegravir may cause hair loss in some patients.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

JAK inhibitors are effective treatments for alopecia areata.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.